Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2000, p. 2419-2423, Vol. 44, No. 9
Departamento de
Microbiologia1 and Departamento de
Patologia Geral,2 ICB-UFMG, 30.161-970 Belo
Horizonte, MG, Brazil
Received 31 January 2000/Returned for modification 31 March
2000/Accepted 7 June 2000
Metronidazole is widely used to treat protozoan and fungal
infections. As an antibacterial drug, it is used mainly against anaerobes. Among anaerobes, the Bacteroides fragilis group
is the most relevant in terms of frequency of recovery and
antimicrobial resistance patterns. The use of metronidazole and other
antimicrobial drugs induces morphological changes in this bacterial
group. The present study investigated in vivo if these morphological
modifications were accompanied by changes in virulence patterns by
using germfree mice experimentally challenged with
metronidazole-resistant Bacteroides strains before and
after exposure to metronidazole. It was observed that
metronidazole-resistant strains were more virulent after contact with
the drug, as demonstrated by anatomicopathologic data for spleen,
liver, and small intestine samples. These results suggest that
long-term therapy and high metronidazole concentrations could interfere
with microbial pathogenicity, resulting in changes to host-bacterium relationships.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Effect of Metronidazole on the Pathogenicity of
Resistant Bacteroides Strains in Gnotobiotic Mice
*
Corresponding author. Mailing address: Departamento de
Microbiologia, ICB-UFMG, Caixa Postal 486, 30.161-970 Belo Horizonte, MG, Brazil. Phone: 55.31.499.27.61. Fax: 55.31.499.27.30. E-mail: marc{at}mono.icb.ufmg.br.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |